Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
36 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
UNICLE BIOMEDICAL DATA SCIENCE from Leuven, company number BE0770950357, closed financial year 2025 with a result of € -66,856 after tax. For that financial year UNICLE BIOMEDICAL DATA SCIENCE recorded a gross margin of € -59,294 and equity of € 172,701. Compared with financial year 2024, the result moved from € 126,869 to € -66,856. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 172,701
▼ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -66,856
▼ still € 126,869 profit in 2024
Profit after tax over the fiscal year.
€ 117,362
▼ 52% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 167,701.
People and assets in 2025
€ 4,292
▼ 92% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,627
▼ 64% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8,634
▼ 74% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 173,391 | € 130,707 | € 183,753 | € -59,294 | ▼ € 243,046 |
| Profit after taxes | € 108,012 | € 29,676 | € 126,869 | € -66,856 | ▼ € 193,725 |
| Equity | € 83,012 | € 112,688 | € 239,557 | € 172,701 | ▼ 28% |
| Total debts | € 174,458 | € 269,655 | € 48,269 | € 15,680 | ▼ 68% |
| Cash | € 53,869 | € 292,628 | € 243,331 | € 117,362 | ▼ 52% |
| Retained profit | € 78,012 | € 107,688 | € 234,557 | € 167,701 | ▼ 29% |
| Dividend | € 30,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 257,469 | € 382,343 | € 287,826 | € 188,381 | ▼ 35% |
Key figures of UNICLE BIOMEDICAL DATA SCIENCE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to UNICLE BIOMEDICAL DATA SCIENCE?
What happened at UNICLE BIOMEDICAL DATA SCIENCE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 66,856 (▼ € 193,725 vs 2024). Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 108,012 profit in 2022 to € 66,856 loss in 2025.
Paid € 27,227 in corporate taxes since 2022.
Best year ever: 2024, with € 126,869 profit.
Paid out € 30,000 in dividends to the owners in total.
A new publication or filing at UNICLE BIOMEDICAL DATA SCIENCE? We notify you, reason included.
Follow UNICLE BIOMEDICAL DATA SCIENCEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind UNICLE BIOMEDICAL DATA SCIENCE are HORIZONS.BIO BV, JSVC ADVIES BV BO and GENADVICE BV.
Directors
According to the 2025 annual accounts
Director · represented by JERMAINE GOVEIA
Director · represented by JASPER SMINK
Director · represented by MATTHIEU MOISSE
Establishments
Establishment units
Physical locations of this company
Kapeldreef 60 box 1.17
3001 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 36 companies are registered at this address.
All companies at this address →Belgische Vereniging voor Oppervlaktetechnieken van Materialen
INNOVATIE- EN INCUBATIECENTRUM K.U. LEUVEN
€ 271,378 gross margin · 2025
Vlaamse Jonge Ondernemingen
€ 1.7 million gross margin · 2025
Metis Instruments & Equipment
€ 466,525 gross margin · 2025
Quality In Treatment
€ 167,339 gross margin · 2025
+31 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0770.950.357
- VAT number
- BE 0770.950.357
- Registered office
- Kapeldreef 60 bus 1.17, 3001 Leuven
- Names & denominations
- UNICLE BIOMEDICAL DATA SCIENCE · UNICLE BDS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 July 2021
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computerconsultancy-activiteiten
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige diensten op het gebied van informatietechnologie en computer
Overige dienstverlenende activiteiten op het gebied van informatie
Gegevensverwerking, webhosting en aanverwante activiteiten
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.
+1